Ironwood Pharmaceuticals, Inc.

US$4.39As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:IRWDHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (8.50%)
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.24
PE TTM 4.841
TSR TTM 128.65%
Mkt cap US$726.8M
ROIC 65.32%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$5.52
25.67%
541.07%
Sell 8|1|6|4|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.07
0.07
0.08
0.08
—
7.62%
17.16%
21.45%
Revenue$M
41.50
42.51
43.32
42.97
8.20%
6.85%
4.34%
5.96%
Peers (US$726.8M)
Cap (US$)
PE
1.008B
—
719.3M
6.072x
Capital
TTM
5Y
10Y
Leveragex
0.389
0.640
0.465
EBIT/Intx
0.069
0.056
0.056
Own earn%
(8.95)
98.40
105.36
Sh yield%
36.23
10.78
10.73
Owners
Insiders/Inst%
11.10
42.37
Short interest%
5.84
SBC / revenue%
4.00
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
5–8
$1 testx
0.1
Incr. ROIC%
3